[1]
Waseem, H. 2022. Cost Effective Antibiotics Versus Meropenem Against Extended Spectrum Beta Lactamase Producing Escherichia Coli from Urine. International Journal of Pathology. 19, 4 (Mar. 2022), 190–193.